Mediating peptide aggregation against amyloid diseases

This project examines peptide aggregation and its induced cell response, as well as the corona formation of protein amyloids in circulation, using state of the art biophysical techniques, a human blood assay and a zebrafish model. The endpoint of the research is to develop novel theranostics against type 2 diabetes and neurodegenerative disorders.

Enhanced research experiences